NanoViricides
NNVC
#10085
Rank
โ‚น2.29 B
Marketcap
โ‚น106.63
Share price
4.42%
Change (1 day)
2.60%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: โ‚น2.29 Billion

As of January 2026 NanoViricides has a market cap of โ‚น2.29 Billion. This makes NanoViricides the world's 10085th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น2.29 B-0.19%
2025โ‚น2.30 B24.8%
2024โ‚น1.84 B85.1%
2023โ‚น0.99 B-6.47%
2022โ‚น1.06 B-66.58%
2021โ‚น3.19 B42.55%
2020โ‚น2.23 B223.11%
2019โ‚น0.69 B-28.72%
2018โ‚น0.97 B-72.69%
2017โ‚น3.55 B-15.9%
2016โ‚น4.23 B-6.67%
2015โ‚น4.53 B-53.5%
2014โ‚น9.75 B-34.29%
2013โ‚น14.83 B262.22%
2012โ‚น4.09 B-14.99%
2011โ‚น4.81 B-47.29%
2010โ‚น9.14 B75.73%
2009โ‚น5.20 B8.9%
2008โ‚น4.77 B161.96%
2007โ‚น1.82 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of NanoViricides was reported to be:

โ‚น2.28 Billion
by Nasdaq info icon info icon
โ‚น2.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioCryst Pharmaceuticals
BCRX
โ‚น126.82 B 5,414.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น117.61 B 5,014.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น14.005 T 608,877.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น10.165 T 441,913.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น24.563 T 1,067,977.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.806 T 382,815.43%๐Ÿ‡ฌ๐Ÿ‡ง UK